Executive Summary

Oct 2019
PROSPECTS
Medicines see price increase in 2019

In January 2019, the Drug Regulatory Authority of Pakistan (DRAP) notified a 15% increase in the retail price of medicines (9% on lifesaving drugs). The price rise came as a result of the weakening of the Pakistan rupee against the dollar, partly in anticipation of a devaluation of the currency as part of an IMF bailout deal, and the resultant increase in raw material and packaging material costs, as well as an increase in electricity and gas tariffs.

Growing confidence in self-medication

The ongoing development of the self-medication trend will be a key contributor to growth in analgesics during the forecast period. Pakistani consumers are increasingly seeking to avoid seeing a doctor unless symptoms are serious, as they become more comfortable with the idea of self-medicating, particularly if products have been recommended by pharmacists.

Increasing investment in marketing and innovation expected

The growing demand for OTC analgesics is expected to stimulate increasing investment in product innovation and marketing activity in the category. Established brands are expected to see the introduction of extensions targeting particular consumer groups and usage occasions, including the launch of novel formats such as sprays and gels.

COMPETITIVE LANDSCAPE
Foreign multinationals dominate

Foreign multinational players remained dominant in analgesics at the end of the review period. Players such as GSK Consumer Healthcare, Abbott Laboratories and Reckitt Benckiser benefit from a long-standing presence in the market and high levels of consumer brand awareness.

Domestic players likely to focus on competitive pricing

In order to build a presence in the face of intense competition from major multinationals, domestic companies are likely to focus on the development of generic products that compete primarily in terms of price. The DRAP’s control of prices limits opportunities for price-based competition.

Marketing activity supports international brands’ strength

While domestic players focus on pricing, the major international analgesics brands seek to differentiate themselves through investment in marketing activity, including mass media advertising on TV and radio, as well as in-store activities. Such marketing support helped GSK Consumer Healthcare’s market-leading Panadol, Abbott Laboratories’ Arinac and Brufen, and Reckitt Benckiser’s Disprin to gain share in the final two years of the review period.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Analgesics in Pakistan

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Pakistan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Pakistan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Pakistan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Pakistan?
  • What are the major brands in Pakistan?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Analgesics in Pakistan - Category analysis

HEADLINES

PROSPECTS

Medicines see price increase in 2019
Growing confidence in self-medication
Increasing investment in marketing and innovation expected

COMPETITIVE LANDSCAPE

Foreign multinationals dominate
Domestic players likely to focus on competitive pricing
Marketing activity supports international brands’ strength

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024

Consumer Health in Pakistan - Industry Overview

EXECUTIVE SUMMARY

City living boosting demand across consumer health
DRAP expected to maintain price control despite 2019 increase
Major multinationals continue to dominate
Advice from store staff growing in importance in light of self-medication trend
Favourable conditions for ongoing growth

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine

DEFINITIONS

SOURCES

Summary 1 Research Sources